Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma

Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial

(2018) Mark M Souweidane et al.   LANCET ONCOLOGY

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

(2017) Sharareh Gholamin et al.   Science Translational Medicine

A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent

(2015) Kyle G. Halvorson et al.   PLoS One

Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas

(2014) Prashant Chittiboina et al.   Journal of Neurosurgery-Pediatrics

Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma

(2014) Nathalène Truffaux et al.   NEURO-ONCOLOGY

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

(2010) S. Kunwar et al.   NEURO-ONCOLOGY

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas

(2008) Hideho Okada et al.   JOURNAL OF NEURO-ONCOLOGY

Identification of interleukin-13 receptor α2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma

(2008) Bharat H. Joshi et al.   NEURO-ONCOLOGY